HansBiomed Corporation reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported sales was KRW 20,452.81 million compared to KRW 20,482.94 million a year ago. Net loss was KRW 51.98 million compared to KRW 9,744.1 million a year ago. Basic loss per share from continuing operations was KRW 4 compared to KRW 964 a year ago. Basic loss per share was KRW 4 compared to KRW 964 a year ago.
For the six months, sales was KRW 40,813.03 million compared to KRW 40,554.05 million a year ago. Net loss was KRW 1,074.7 million compared to KRW 14,117.01 million a year ago. Basic loss per share from continuing operations was KRW 83 compared to KRW 1,433 a year ago. Basic loss per share was KRW 83 compared to KRW 1,433 a year ago.